Pulmonary embolism risk stratification: where are we heading?

Paiva Luis, Barra Sérgio, Providência Rui

Source: Eur Respir J 2014; 43: 298-300
Journal Issue: January

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paiva Luis, Barra Sérgio, Providência Rui. Pulmonary embolism risk stratification: where are we heading?. Eur Respir J 2014; 43: 298-300

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary emboli and COVID-19: an increased risk for all?
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021


Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both?
Source: Eur Respir J 2015; 46: 1551-1553
Year: 2015


Do we ever learn? Risk stratification and investigation of suspected pulmonary embolism
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013


Pulmonary embolism and COVID-19: a “special phenotype”?
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021


Can syncope be used for the risk assessment of pulmonary embolism?
Source: International Congress 2017 – Pulmonary embolism
Year: 2017

Pulmonary embolism in young people: risk factors and clinical presentation
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Severe pulmonary sarcoidosis: definition and risk stratification
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020


Fatal pulmonary embolism in young people: risk factors and clinical presentation
Source: Annual Congress 2009 - Intensive care unit management and outcome
Year: 2009

Pulmonary embolism and pulmonary hypertension - is our follow up adequate?
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005

Is there a role for risk stratification for ambulatory management of Pulmonary Embolism?
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017


Chronic thromboembolic disease following pulmonary embolism: more work ahead
Source: Eur Respir J, 55 (4) 2000229; 10.1183/13993003.00229-2020
Year: 2020



Original, simplified, and modified pulmonary embolism severity indices in risk stratification of pulmonary embolism
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020

Pulmonary embolism and the consequences for the right heart
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136
Year: 2006

Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020


Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Acute pulmonary embolism: a specific scent?
Source: International Congress 2017 – Pulmonary embolism
Year: 2017


Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021



Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014


The management and follow-up of pulmonary embolism (PE) at a district general hospital: Are we missing CTEPH?
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021
Year: 2022